Sign in / Join Now
ETFs & Funds
is a generic pharmacutical company which appears to have good possibilities.
Add a reply...
Latest StockTalks »
people get MNTA breaking news and analysis by email alert.
Get email alerts on MNTA »
Momenta Pharmaceuticals, Inc.
Get latest price
From other sites
Momenta Pharmaceuticals Announces Date For Third Quarter 2016 Financial Results Conference Call And Webcast
at TheStreet (Thu, 8:00AM)
Momenta Pharmaceuticals (MNTA) Jumps: Stock Up 12.7%
at Zacks.com (Oct 12, 2016)
Momenta Pharmaceuticals (MNTA) Stock Surges, Barclays Upgrades
at TheStreet (Oct 11, 2016)
A Compelling Risk/Reward Seen In Momenta Pharmaceuticals
at Benzinga (Oct 11, 2016)
Momenta Pharmaceuticals To Regain Global Development And Commercialization Rights To M923, A Proposed Biosimilar Of HUMIRA® (adalimumab), Through Termination Of Collaboration Agreement With Baxalta, Now Part Of Shire
at TheStreet (Sep 27, 2016)